title: Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study.
abstract: OBJECTIVE
  To determine: (1) achievement of cholesterol therapy goals in patients receiving lipid-lowering drugs in Polish primary care between the years 2004 and 2006; (2) the characteristics of patients that are associated with attainment of these goals.
  
  
  METHODS
  Cross-sectional study in randomly selected Polish primary care practices.
  
  
  METHODS
  5248 patients aged over 30 years in 2004 and 5386 patients in 2006, who were taking cholesterol-lowering treatment took part in the study. Physicians recorded demographic and medical history data using a standardized questionnaire, including weight and height, and collected blood samples of patients to determine their cholesterol level.
  
  
  RESULTS
  18.5% of patients attained their optimal goals of therapy (total cholesterol, TC; low-density lipoprotein cholesterol, LDL-C) in 2004 compared to 25.2% in 2006 (p < 0.001). In both 2004 and 2006, more patients achieved their target levels for LDL-C than for TC and statins were the most commonly used medication (85% and 91%, respectively). Male sex, smoking, and higher education were the strongest correlates of the therapeutic outcome. The odds ratio of achieving cholesterol therapy goals in men, non-smokers, and university graduates was estimated at 1.51, 0.70, 1.38 in 2004 and 1.50, 0.73, 1.34 in 2006, respectively.
  
  
  CONCLUSIONS
  There was a measurable improvement in the effectiveness of hypercholesterolaemia treatment between 2004 and 2006 but the majority of patients remain inadequately treated, with goals not being achieved. There is a need to raise the standard of lipid-lowering management in Poland.
authors: Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, Kraków, Poland. mmtomasi@cyf-kr.edu.pl
authors: Tomasz
authors: T
authors: Tomasik
authors: Jacek
authors: J
authors: Jozwiak
authors: Adam
authors: A
authors: Windak
authors: Katarzyna
authors: K
authors: Rygiel
authors: Miroslaw
authors: M
authors: Mastej
authors: W Henry
authors: WH
authors: Smithson
authors: Nigel
authors: N
authors: Mathers
authors: Maciej
authors: M
authors: Tomaszewski
authors: Bernhard M
authors: BM
authors: Kaess
authors: Andrzej
authors: A
authors: Tykarski
authors: Ewa
authors: E
authors: Konduracka
authors: Wladyslaw
authors: W
authors: Grzeszczak
authors: Witold
authors: W
authors: Lukas
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D004363:Drug Utilization; D005260:Female; D019983:Guideline Adherence; D019538:Health Care Surveys; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011044:Poland; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D011314:Preventive Health Services / Q000706:statistics & numerical data; D011320:Primary Health Care / Q000706:statistics & numerical data; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D015415:Biomarkers; D008078:Cholesterol, LDL; D002784:Cholesterol